Clinical Autonomic Research

, Volume 23, Issue 6, pp 305–311 | Cite as

What is brain fog? An evaluation of the symptom in postural tachycardia syndrome

  • Amanda J. Ross
  • Marvin S. Medow
  • Peter C. Rowe
  • Julian M. Stewart
Research Article

Abstract

Purpose

Adolescents with postural tachycardia syndrome (POTS) often experience ill-defined cognitive impairment referred to by patients as “brain fog.” The objective of this study was to evaluate the symptom of brain fog as a means of gaining further insight into its etiology and potential palliative interventions.

Methods

Eligible subjects who reported having been diagnosed with POTS were recruited from social media web sites. Subjects were asked to complete a 38-item questionnaire designed for this study, and the Wood mental fatigue inventory (WMFI).

Results

Responses were received from 138 subjects with POTS (88 % female), ranging in age from 14 to 29 years; 132 subjects reported brain fog. WMFI scores correlated with brain fog frequency and severity (P < 0.001). The top ranked descriptors of brain fog were “forgetful,” “cloudy,” and “difficulty focusing, thinking and communicating.” The most frequently reported brain fog triggers were fatigue (91 %), lack of sleep (90 %), prolonged standing (87 %), dehydration (86 %), and feeling faint (85 %). Although aggravated by upright posture, brain fog was reported to persist after assuming a recumbent posture. The most frequently reported interventions for the treatment of brain fog were intravenous saline (77 %), stimulant medications (67 %), salt tablets (54 %), intra-muscular vitamin B-12 injections (48 %), and midodrine (45 %).

Conclusions

Descriptors for “brain fog” are most consistent with it being a cognitive complaint. Factors other than upright posture may play a role in the persistence of this symptom. Subjects reported a number of therapeutic interventions for brain fog not typically used in the treatment of POTS that may warrant further investigation.

Keywords

Postural tachycardia syndrome Orthostatic intolerance Cognition 

References

  1. 1.
    Singer W, Sletten DM, Opfer-Gehrking TL, Brands CK, Fischer PR, Low PA (2012) Postural tachycardia in children and adolescents: what is abnormal? J Pediatr 160:222–226PubMedCrossRefGoogle Scholar
  2. 2.
    Stewart JM (2012) Update on the theory and management of orthostatic intolerance and related syndromes in adolescents and children. Expert Rev Cardiovasc Ther 10:1387–1399PubMedCrossRefGoogle Scholar
  3. 3.
    Ocon AJ, Medow MS, Taneja I, Clarke D, Stewart JM (2009) Decreased upright cerebral blood flow and cerebral autoregulation in normocapnic postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 297:H664–H673PubMedCrossRefGoogle Scholar
  4. 4.
    Ocon AJ, Messer ZR, Medow MS, Stewart JM (2012) Increasing orthostatic stress impairs functioning in chronic fatigue syndrome with postural tachycardia syndrome. orthostasis impairs neurocognition in POTS. Clin Sci 122:227–238PubMedCrossRefGoogle Scholar
  5. 5.
    Arnold AC, Haman K, Garland EM, Paranjape SY, Shibao CA, Biaggioni I, Robertson D, Raj SR (2012) Origins of cognitive dysfunction in postural tachycardiasyndrome. Clin Auton Res 22:207–258CrossRefGoogle Scholar
  6. 6.
    Karas B, Grubb BP, Boehm K, Kip K (2000) The postural orthostatic tachycardia syndrome: a potentially treatable cause of chronic fatigue, exercise intolerance, and cognitive impairment in adolescents. Pac Clin Electrophysiol 23:344–351CrossRefGoogle Scholar
  7. 7.
    Plash WB, Diedrich A, Biaggioni I, Garland EM, Paranjape SY, Black BK, Dupont WD, Raj SR (2013) Diagnosing postural tachycardia syndrome: comparison of tilt testing compared with standing haemodynamics. Clin Sci (Lond) 124:109–114CrossRefGoogle Scholar
  8. 8.
    Muth ER, Stern RM, Thayer JF, Koch KL (1996) Assessment of the multiple dimensions of nausea: the Nausea Profile (NP). Psychosom Res 40:511–520CrossRefGoogle Scholar
  9. 9.
    Bentall RP, Wood GC, Marrinam T, Dears C, Edwards RHT (1993) A brief mental fatigue questionnaire. Br J Clin Psychol 32:375–379PubMedCrossRefGoogle Scholar
  10. 10.
    Bou-Holaigah I, Rowe PC, Kan J, Calkins H (1995) The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 274:961–967PubMedCrossRefGoogle Scholar
  11. 11.
    Zung WWK (1972) The depression status inventory: an adjunct to the self-rating depression scale. J Clin Psychol 28:539–554PubMedCrossRefGoogle Scholar
  12. 12.
    Manyari DE, Rose S, Tyberg JV, Sheldon RS (1996) Abnormal reflex venous function in patients with neuromediated syncope. JACC 27:1730–1735PubMedCrossRefGoogle Scholar
  13. 13.
    Ohayon MM, Roberts RE, Zulley J, Smirne S, Priest RG (2000) Prevalence and patterns of problematic sleep among older adolescents. J Am Acad Child adolsec Psychiatry 39:1549–1556CrossRefGoogle Scholar
  14. 14.
    Bagai K, Wakwe CI, Beth Malow B, Black BK, Biaggioni I, Paranjape SY, Orozco C, Raj SR (2013) Estimation of sleep disturbances using wrist actigraphy in patients withpostural tachycardia syndrome. Auton Neurosci. doi:10.1016/j.autneu.2013.02.021 PubMedGoogle Scholar
  15. 15.
    Bagai K, Song Y, Ling JF, Malow B, Black BK, Biaggioni I, Robertson D, Raj SR (2011) Sleep disturbances and diminished quality of life in postural tachycardia syndrome. J Clin Sleep Med 7:204–210PubMedGoogle Scholar
  16. 16.
    Deak MC, Stickgold R (2010) Sleep and Cognition. WIREs Cognitive Sci 1:491–500Google Scholar
  17. 17.
    Claydon VE, Hainsworth R (2004) Salt supplementation improves orthostatic cerebral and peripheral vascular control in patients with syncope. Hypertension 43(4):809–813PubMedCrossRefGoogle Scholar
  18. 18.
    Jarvis MJ (1992) Does caffeine intake enhance absolute levels of cognitive performance? Psychopharmacology 110:45–52CrossRefGoogle Scholar
  19. 19.
    Jacob G, Shannon JR, Black B, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D (1997) Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation 96(2):575–580PubMedCrossRefGoogle Scholar
  20. 20.
    Gordon VM, Opfer-Gehrking TL, Novak V, Low PA (2000) Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome. Clin Auton Res 10(1):29–33PubMedCrossRefGoogle Scholar
  21. 21.
    Raj SR, Black BK, Biaggioni I, Sachin PY, Ramirez M, Dupont WD, Robertson D (2009) Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome (pots): less is more. Circulation 120:725–734PubMedCrossRefGoogle Scholar
  22. 22.
    Biringer E, Rongvel A, Lund A (2009) A review of modern antidepressants’ effects on neurocognitive function. Curr Psychiatry Rev 5:1–11CrossRefGoogle Scholar
  23. 23.
    Joyner MJ, Masuki S (2008) POTS versus deconditioning: the same or different? Clin Auton Res 18:300–307PubMedCrossRefGoogle Scholar
  24. 24.
    Fu Q, VanGundy TB, Shibata S, Auchus RJ, Williams GH, Levine BD (2011) Exercise training versus propanolol in the treatment of the postural tachycardia syndrome. Hypertension 58:167–175PubMedCrossRefGoogle Scholar
  25. 25.
    Hillman CH, Erickson KI, Kramer AF (2008) Be smart, exercise your heart: exercise effects on brain and cognition. Nat Rev Neurosci 9:58–65PubMedCrossRefGoogle Scholar
  26. 26.
    Benarroch EE (2012) Postural tachycardia syndrome: a heterogeneous and multifactorial disorder. Mayo Clin Proc 87:1214–1215PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Amanda J. Ross
    • 1
  • Marvin S. Medow
    • 2
  • Peter C. Rowe
    • 3
  • Julian M. Stewart
    • 2
    • 4
  1. 1.Department of Behavioral BiologyJohns Hopkins UniversityBaltimoreUSA
  2. 2.Departments of Physiology and PediatricsNew York Medical CollegeValhallaUSA
  3. 3.Department of PediatricsJohns Hopkins University School of MedicineBaltimoreUSA
  4. 4.New York Medical College, Center for HypotensionHawthorneUSA

Personalised recommendations